BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27248819)

  • 1. Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis.
    Gao L; Hong X; Guo X; Cao D; Gao X; DeLaney TF; Gong X; Chen R; Ni J; Yao Y; Wang R; Chen X; Tian P; Xing B
    Oncotarget; 2016 Jul; 7(28):43557-43569. PubMed ID: 27248819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct IDH1/2-associated Methylation Profile and Enrichment of
    Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
    Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
    Lucas CG; Grenert JP; Horvai A
    Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of TP53 mutations determined by next-generation "deep" sequencing in prognosis of estrogen receptor-positive breast cancer.
    Uji K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
    Cancer Lett; 2014 Jan; 342(1):19-26. PubMed ID: 23973262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glandular differentiation in dedifferentiated chondrosarcoma: molecular evidence of a rare phenomenon.
    Jour G; Liu Y; Ricciotti R; Pritchard C; Hoch BL
    Hum Pathol; 2015 Sep; 46(9):1398-404. PubMed ID: 26198745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.
    Deb S; Wong SQ; Li J; Do H; Weiss J; Byrne D; Chakrabarti A; Bosma T; ; Fellowes A; Dobrovic A; Fox SB
    Br J Cancer; 2014 Dec; 111(12):2351-60. PubMed ID: 25490678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
    Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
    Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
    Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
    J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
    Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
    Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
    Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B
    J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression in dedifferentiated chondrosarcoma.
    Simms WW; Ordóñez NG; Johnston D; Ayala AG; Czerniak B
    Cancer; 1995 Jul; 76(2):223-7. PubMed ID: 8625095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
    Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
    Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
    Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
    Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population.
    Hussain I; ul Rehman S; Afroze D; Zahoor L; Abdullah S; Hafiz A; Shah ZA; Iqbal S; Shaffi M; Das BC; Siddiqi MA
    Mutat Res; 2009 May; 676(1-2):5-10. PubMed ID: 19486858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
    Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
    Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
    Xu X; Tang X; Guo W; Yang K; Ren T
    Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.